Description
A selective, ATP-competitive inhibitor of the serine/threonine kinase, glycogen synthase kinase 3β (Ki = 38 nM; IC50 = 104 nM); demonstrates neuroprotective effects by inhibiting tau phosphorylation (IC50 = 2.7 μM) at a GSK3-specific site (Ser396) in cells stably expressing human four-repeat tau protein and also by protecting β-amyloid-exposed N2A neuroblastoma cells against cell death
Formal name: N-[(4-methoxyphenyl)methyl]-N’-(5-nitro-2-thiazolyl)-urea
Synonyms: AR 0133418|AR 014418|Glycogen Synthase Kinase 3β Inhibitor VIII|SN 4521
Molecular weight: 308.3
CAS: 487021-52-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|GSK3||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease